Answer
In clinical studies of patients with compensated liver disease, the most common adverse reactions of any severity considered at least possibly related to entecavir were headache (9%), fatigue (6%), dizziness (4%) and nausea (3%).
Sources for this answer
- Baraclude 0.05 mg/ml oral solutionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.8 Undesirable effects · Version 6Document updated
Sources checked